Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study
The LancetPublished 1 April 2000
Eivind Berge, Michael Abdelnoor, PH Nakstad, PM Sandset
Citations422
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The present data do not provide any evidence that LMWH is superior to aspirin for the treatment of acute ischaemic stroke in patients with atrial fibrillation, and the study could not exclude the possibility of smaller, but still worthwhile, effects of either of the trial drugs.
Abstract
The present data do not provide any evidence that LMWH is superior to aspirin for the treatment of acute ischaemic stroke in patients with atrial fibrillation. However, the study could not exclude the possibility of smaller, but still worthwhile, effects of either of the trial drugs.
Keywords
Medicine
StrokeAtrial fibrillation as an independent risk factor for stroke: the Framingham Study.
7,462 Citations1991Philip A. Wolf, Robert D. Abbott +1 more
The data suggest that the elderly are particularly vulnerable to stroke when atrial fibrillation is present, and the effects of hypertension, coronary heart disease, and cardiac failure on the risk of stroke became progressively weaker with increasing age.
StrokeInterobserver agreement for the assessment of handicap in stroke patients.
6,454 Citations1988John C. van Swieten, Peter J. Koudstaal +3 more
The results confirm the value of the modified Rankin scale in the assessment of handicap in stroke patients; nevertheless, further improvements are possible.
The LancetClassification and natural history of clinically identifiable subtypes of cerebral infarction
3,270 Citations1991John Bamford, Peter Sandercock +3 more
There were striking differences in natural history between the groups and the findings have important implications for the planning of stroke treatment trials and suggest that various therapies could be directed specifically at the subgroups.
Journal of the American Statistical AssociationEpidemiologic Research: Principles and Quantitative Methods.
2,942 Citations1984Lawrence S. Mayer, David G. Kleinbaum +2 more
JAMAIntravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke
2,362 Citations1995Werner Hacke
Intravenous thrombolysis in acute ischemic stroke is effective in improving some functional measures and neurologic outcome in a defined subgroup of stroke patients with moderate to severe neurologic deficit and without extended infarct signs on the initial CT scan, however, the identification of this subgroup is difficult.
The LancetThe International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1,890 Citations1997Peter Sandercock
Aspirinallocated patients had significantly fewer recurrent ischaemic strokes within 14 days with no significant excess of haemorrhagic strokes, so the reduction in death or non-fatal recurrent stroke with aspirin was significant.
The LancetSecondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1,744 Citations1993EAFT Study Group
It is concluded that anticoagulation is effective in reducing the risk of recurrent vascular events in NRAF patients with a recent TIA or minor ischaemic stroke; it prevents 40 vascular events each year for every 1000 treated patients.
New England Journal of MedicineA Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1,432 Citations1997Marc J. Cohen, Christine Demers +11 more
Antithrombotic therapy with enoxaparin plus aspirin was more effective than unfractionated heparin plus aspirin in reducing the incidence of ischemic events in patients with unstable angina or non-Q-wave myocardial infarction in the early phase.
StrokeThe Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.
1,345 Citations1988Julien Bogousslavsky, Guy van Melle +1 more
The LancetCAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke
1,222 Citations1997Christopher Chen
Taken together, CAST and the similarly large IST show reliably that aspirin started early in hospital produces a small but definite net benefit, with about 9 (SD 3) fewer deaths or non-fatal strokes per 1000 in the first few weeks, and with 13 (5) fewer dead or dependent per 1000 after some weeks or months of follow-up.
BloodLow molecular weight heparin
903 Citations1992J. Hirsh, Levine Mn
The mechanism for the difference between the anticoagulant profiles of LMWHs and SH has been elucidated and studies of platelet function and vascular permeability have provided plausible explanations for the reduced experimental bleeding observed with LMWHs.
The LancetLow-molecular-weight heparin during instability in coronary artery disease
686 Citations1996Fragmin during Instability in Coronary Artery Disease (FRISC) study group
PubMedCardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
548 Citations1989Richard Asinger, Mark L. Dyken +3 more
Low-intensity anticoagulation (international normalized ratio, 2.0 to 3.0) may be sufficient prophylaxis for many embolism-prone cardiac disorders and may be indicated for primary stroke prevention in high-risk patient subgroups with non-rheumatic atrial fibrillation.
JAMALow Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial
526 Citations1998The Publications Committee for the Trial of ORG in Acute Stroke Treatment Investigators
StrokeAcute Stroke With Atrial Fibrillation
521 Citations1996Henrik Jørgensen, Hirofumi Nakayama +3 more
Stroke in patients with AF is generally more severe and outcome markedly poorer than in Patients with sinus rhythm, which accentuates the importance of anticoagulant treatment of individuals with AF.
StrokeGuidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
494 Citations1994Harold P. Adams, Thomas Brott +8 more
This special report provides information about the current management of acute ischemic stroke and provides recommendations for initial care based on currently available data from clinical trials and predicts that many therapies for stroke will be linked to very early intervention.
The European Cooperative Acute Stroke Study (ECASS)
485 Citations1993Markku Kaste, C. Fieschi +4 more
Stroke therapies have been aimed at the prevention of future cerebrovascular attacks, but no therapy is available to improve the outcome of patients with ischemic stroke.
New England Journal of MedicineLow-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke
476 Citations1995R. Kay, Ka Sing Wong +9 more
For patients with ischemic stroke treated within 48 hours of the onset of symptoms, low-molecular-weight heparin was effective in improving outcomes at six months, and no significant differences among the groups in the occurrence of secondary outcomes were observed at 10 days.
Cochrane Database of Systematic ReviewsAnticoagulants for acute ischaemic stroke
347 Citations2008Peter Sandercock, Carl Counsell +1 more
Treatment with anticoagulants reduced recurrent stroke, deep vein thrombosis and pulmonary embolism, but increased bleeding risk, and the data do not support the routine use of any the currently available anticoAGulants in acute ischaemic stroke.
BMJComparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
306 Citations1994Alain Leizorovicz, Gérald Simonneau +2 more
Low molecular weight heparins seem to have a higher benefit to risk ratio than unfractionated heparin in the treatment of venous thrombosis, however, these results remain to be confirmed by using clinical outcomes in suitably powered clinical trials.
StrokeImmediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
304 Citations1983
Data support immediate anticoagulation of nonhypertensive patients with embolic brain infarction who have no evidence of hemorrhage on CT performed 24-48 hours after stroke.
StrokeImmediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.
267 Citations1984
The clinical implications of hemorrhagic transformation of embolic brain infarction were explored by studying 30 patients with cardiogenic brain embolism and either hemorrhagic infarct (HI) or intracerebral hematoma on CT, finding a delay of several days before anticoagulation and special efforts to avoid excessive anticoageulation and hypertension may be prudent.
BMJAtrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)
254 Citations1992Peter Sandercock, John Bamford +6 more
After a first stroke atrial fibrillation was not associated with a definite excess risk of recurrent stroke, either within 30 days or within the first few years.
Journal of the Neurological SciencesIschaemic cerebrovascular diseases in an autopsy series Part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts
217 Citations1969L. Jörgensen, A. Torvik
Among 994 consecutive autopsies, 320 cases of ischaemic cerebrovascular disease were found; in 196 of the cases the disease had given clinical symptoms; they constitute 76.3% of all patients with stroke.
HaemostasisProphylaxis of Deep Venous Thrombosis with a Low-Molecular-Weight Heparin (Kabi 2165/Fragmin®) in Stroke Patients
111 Citations2009Martin H. Prins, R.G. Gelsema +3 more
Cerebrovascular DiseasesDeteriorating Stroke: Diagnostic Criteria, Predictors, Mechanisms and Treatment
106 Citations1999José Castillo
In both types of stroke, neurological deterioration is associated with increased mortality and morbidity and early detection and prediction of neurological deterioration, identification of the responsible mechanisms and their correction, are the basis of an effective therapy.
PubMedA double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
103 Citations1990Per Morten Sandset, Trond Dahl +4 more
It is concluded that LMW heparin in the dose range studied did not provide efficient prophylaxis against DVT in patients with acute ischemic stroke.
NeurologyUse of antithrombotic drugs in the treatment of acute ischemic stroke
74 Citations1989E. Eugene Marsh, Harold P. Adams +5 more
Results of a future trial testing the efficacy of antithrombotic drugs would be useful for most neurologists in their management of patients with acute or progressing ischemic stroke.
Cerebrovascular DiseasesAntithrombotic Drugs:Insights f rom Cardiology
64 Citations1998Beat J. Meyer
The primary purpose of this overview is to provide an update on the newer antiplatelet drugs evaluated in clinical trials and introduced in clinical practice of modern cardiology.
Archives of Internal MedicineCardioembolic Stroke, Early Anticoagulation, and Brain Hemorrhage
51 Citations1987
Journal of the Royal College of Physicians of LondonAcute Stroke Treatment in UK Hospitals: The Stroke Association Survey of Consultant Opinion
47 Citations1995Richard I. Lindley, E O Amayo +4 more
Aspirin and heparin alone are the only routinely used treatments for the immediate treatment of acute stroke; other treatments are used sparingly or not at all.
Cerebrovascular DiseasesAre Simple Questions a Valid Measure of Outcome after Stroke?
34 Citations1997Martin Dennis, Ian Wellwood +1 more
The aim was to farther establish the validity of a novel measure of stroke outcome which has been developed for use in large randomised trials and to identify survivors from a consecutive series of strokes.
Cerebrovascular DiseasesHow Reliable Are Simple Questions in Assessing Outcome after Stroke?
29 Citations1997Martin Dennis, Ian Wellwood +3 more
This study aimed to establish the inter-rater reliability of a novel measure of stroke outcome which has been developed for use in large randomised trials and which could be used in any large follow-up trials.
Postgraduate Medical JournalConsultant views on the use of aspirin in acute cerebrovascular disease: implications for clinical trials
6 Citations1994James E. Kent, John Bamford
It is suggested that aspirin is probably being prescribed acutely after stroke to a significant number of patients and often without a pretreatment CT scan, and it would be ethical for acute treatment trials to allow randomization to aspirin without prior CT scan.
CHEST JournalAntithrombotic Therapy in Atrial Fibrillation
5 Citations1996Warren J. Manning, David I. Silverman
The author reveals the risk factors of thromboembolitic complications of atrial fibrillation and gives guidelines on prescribing antiplatelet drugs that have proved their efficiency in preventive practices.
Cerebrovascular DiseasesDalteparin in Acute Ischemic Cerebrovascular Disease: A Safety Study
5 Citations1997Trond Dahl, Pål Friis +1 more